Details for Patent: 8,067,431
✉ Email this page to a colleague
Which drugs does patent 8,067,431 protect, and when does it expire?
Patent 8,067,431 protects MOVANTIK and is included in one NDA.
This patent has forty-four patent family members in twenty-five countries.
Summary for Patent: 8,067,431
| Title: | Chemically modified small molecules |
| Abstract: | Methods of modifying the rate of systemic absorption of a drug administered to a subject by a pulmonary route, the method comprising covalently conjugating a hydrophilic polymer to a drug, wherein the drug has a half-life of elimination from the lung of less than about 180 minutes, to form a drug-polymer conjugate, wherein the drug-polymer conjugate has a net hydrophilic character and a weight average molecular weight of from about 50 to about 20,000 Daltons, and wherein the half-life of elimination from the lung of the drug-polymer conjugate is at least about 1.5-fold greater than the half-life of elimination from the lung of the drug, wherein the half-life of elimination from the lung is measured by bronchoalveolar lavage followed by assaying residual lung material. |
| Inventor(s): | Fishburn; C. Simone (Redwood City, CA), Lechuga-Ballesteros; David (San Jose, CA), Viegas; Tacey (Madison, AL), Kuo; Mei-Chang (Palo Alto, CA), Song; Yuan (Belmont, CA), Gursahani; Hema (Foster City, CA), Leach; Chester (Tijeras, NM) |
| Assignee: | Nektar Therapeutics (San Francisco, CA) |
| Application Number: | 12/710,167 |
|
Patent Claim Types: see list of patent claims | Use; Dosage form; |
Drugs Protected by US Patent 8,067,431
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valinor | MOVANTIK | naloxegol oxalate | TABLET;ORAL | 204760-001 | Sep 16, 2014 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | TREATMENT OF OPIOID-INDUCED CONSTIPATION | ⤷ Sign Up | ||||
| Valinor | MOVANTIK | naloxegol oxalate | TABLET;ORAL | 204760-002 | Sep 16, 2014 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | TREATMENT OF OPIOID-INDUCED CONSTIPATION | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,067,431
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 1694363 | ⤷ Sign Up | 122015000037 | Germany | ⤷ Sign Up |
| European Patent Office | 1694363 | ⤷ Sign Up | C300737 | Netherlands | ⤷ Sign Up |
| European Patent Office | 1694363 | ⤷ Sign Up | CA 2015 00028 | Denmark | ⤷ Sign Up |
| European Patent Office | 1694363 | ⤷ Sign Up | PA2015019 | Lithuania | ⤷ Sign Up |
| European Patent Office | 1694363 | ⤷ Sign Up | 1590027-7 | Sweden | ⤷ Sign Up |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
